Improve Warfarin Therapy or Use Dabigatran for Patients with Atrial Fibrillation - A Cost-Effectiveness Analysis

被引：0
|
作者：
You, Joyce H. [1 ]
Tsui, Kia K. [1 ]
Wong, Raymond S.
Cheng, Gregory
机构：
[1] Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 51卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1334 / 1334
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Patients With Atrial Fibrillation-A Real Patient Data Analysis in a Hong Kong Teaching Hospital
    Chang, Andy M.
    Ho, Jason C. S.
    Yan, Bryan P.
    Yu, Cheuk Man
    Lam, Yat Yin
    Lee, Vivian W. Y.
    CLINICAL CARDIOLOGY, 2013, 36 (05) : 280 - 285
  • [42] Cost-effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients
    Hallinen, Taru
    Soini, Erkki J.
    Linna, Miika
    Saarni, Samuli I.
    SPRINGERPLUS, 2016, 5
  • [43] Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
    Eckman, Mark H.
    Rosand, Jonathan
    Greenberg, Steven M.
    Gage, Brian F.
    ANNALS OF INTERNAL MEDICINE, 2009, 150 (02) : 73 - U31
  • [44] Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany
    Krejczy, Martin
    Harenberg, Job
    Wehling, Martin
    Obermann, Konrad
    Lip, Gregory Y. H.
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [45] COST-EFFECTIVENESS OF WARFARIN AND ASPIRIN FOR PROPHYLAXIS OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL-FIBRILLATION
    GAGE, BF
    CARDINALLI, AB
    ALBERS, GW
    OWENS, DK
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (23): : 1839 - 1845
  • [46] Dabigatran versus Warfarin in Patients with Atrial Fibrillation
    Worthington, John M.
    Gattellari, Melina
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (27): : 2672 - 2673
  • [47] Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease A Cost-Effectiveness Analysis
    Vargas, Estefania Ruiz
    Sposato, Luciano A.
    Lee, Spencer A. W.
    Hachinski, Vladimir
    Cipriano, Lauren E.
    STROKE, 2018, 49 (12) : 2844 - 2850
  • [48] COST-EFFECTIVENESS BASED PRICING FOR DABIGATRAN FOR THE PRIMARY PROPHYLAXIS OF STROKE IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
    Patel, Rajesh
    Medow, Mitchell
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 : 249 - 249
  • [49] Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
    Choi, Jiyoon C.
    DiBonaventura, Marco D.
    Kopenhafer, Lewis
    Nelson, Winnie W.
    PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 167 - 177
  • [50] STROKE PROPHYLAXIS WITH WARFARIN AND DABIGATRAN FOR PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION - A COST ANALYSIS
    Ali, A. N.
    Bailey, C.
    Abdulhafiz, A. H.
    AGE AND AGEING, 2013, 42 : 31 - 31
12345